Block Grant Program (Fiscal Year 2024)
The OOCC is distributing $4 million through its Block Grant Program, which ensures that all of Maryland’s 24 local jurisdictions receive a base level of funding to support overdose-related programs and initiatives. The program also takes into account local impacts of the opioid crisis and distributes half of the funds proportionally based on overdose mortality rates. These funds are distributed directly to local jurisdictions and will be administered by local health departments. The full list of FY 2024 block grant awards is available here.Competitive Grant Program (Fiscal Year 2024)
The purpose of the OOCC’s Competitive Grant Program is to distribute grant funding to the highest-scoring proposals received from state and local governments and community-based partners that serve to meet the greatest needs around the state. The funding available for the OOCC’s FY 24 Competitive Grants Program is approximately $6 million. The full list of FY 2024 competitive grant awards is available here.Access to Recovery Emergency Gap Funds Grant Program
The Opioid Operational Command Center’s new Access to Recovery Emergency Gap Funds Grant Program distributes funds to cover emergency expenses, such as transportation and extended stays in recovery programs. Organizations that work with individuals in recovery, such as recovery-focus community organizations, recovery residences that have been certified by the Behavioral Health Administration of the Maryland Department of Health, local health departments, and local behavioral health authorities will be eligible to receive funding through this program. The full list of Access to Recovery Emergency Gap Funds Grant Program awards in FY 2023 is available here.Examination and Treatment Act Grant Program
The OOCC will distribute $7.5 million in grant awards to support local jurisdictions with implementing the requirements of the Opioid Use Disorder Examination and Treatment Act (ETA) of 2019. This legislation requires that all local detention centers implement programs to screen incarcerated individuals for opioid use disorder, offer peer recovery specialist services and counseling services to develop re-entry plans for individuals upon release, and to offer all three FDA-approved formulations of medications for opioid use disorder, such as methadone or buprenorphine, in their facilities.The grant awards will support projects in 16 local detention facilities, a summary of which can be found here.
1-888-373-7888
233733